Scarica l'app Stockscreener
0.7712
0.17%
0.0013
Dopo l'orario di chiusura:
.77
-0.0012
-0.16%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$0.7699
Aprire:
$0.78
Volume 24 ore:
227.69K
Relative Volume:
0.21
Capitalizzazione di mercato:
$99.62M
Reddito:
-
Utile/perdita netta:
$-26.91M
Rapporto P/E:
-3.5055
EPS:
-0.22
Flusso di cassa netto:
$-19.57M
1 W Prestazione:
+2.27%
1M Prestazione:
-7.50%
6M Prestazione:
+5.30%
1 anno Prestazione:
-43.29%
Intervallo 1D:
$0.7645
$0.78
Intervallo di 1 settimana:
$0.75
$0.783
Portata 52W:
$0.5526
$1.66
Atossa Therapeutics Inc Stock (ATOS) Company Profile
Nome
Atossa Therapeutics Inc
Settore
Industria
Telefono
206.588.0256
Indirizzo
10202 5TH AVENUE NE, SEATTLE, WA
Confronta ATOS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ATOS
Atossa Therapeutics Inc
|
0.7712 | 98.89M | 0 | -26.91M | -19.57M | -0.22 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Atossa Therapeutics Inc Stock (ATOS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2018-01-26 | Iniziato | Maxim Group | Buy |
Atossa Therapeutics Inc Borsa (ATOS) Ultime notizie
NioCorp and Atossa Therapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The News-Press
Forecasting Atossa Therapeutics Inc. price range with options dataMarket Growth Summary & Short-Term Trading Opportunity Alerts - Newser
Full technical analysis of Atossa Therapeutics Inc. stockPortfolio Performance Summary & AI Driven Price Forecasts - Newser
What to expect from Atossa Therapeutics Inc. in the next 30 daysPortfolio Growth Summary & Stock Timing and Entry Methods - Newser
What technical models suggest about Atossa Therapeutics Inc.’s comebackJuly 2025 PreEarnings & Stepwise Trade Execution Plans - Newser
Can technical indicators confirm Atossa Therapeutics Inc.’s reversal2025 Historical Comparison & Growth Oriented Trade Recommendations - Newser
Using RSI to spot recovery in Atossa Therapeutics Inc.July 2025 Levels & AI Based Buy and Sell Signals - Newser
Has Atossa Therapeutics Inc. found a price floor2025 Investor Takeaways & Weekly Momentum Picks - Newser
Real time social sentiment graph for Atossa Therapeutics Inc.Market Trend Review & Stepwise Trade Signal Implementation - Newser
What to do if you’re stuck in Atossa Therapeutics Inc.2025 Price Momentum & Expert Approved Trade Ideas - Newser
Custom watchlist performance reports with Atossa Therapeutics Inc.Trade Ideas & Real-Time Chart Breakout Alerts - Newser
What recovery options are there for Atossa Therapeutics Inc.Weekly Trade Recap & Precise Trade Entry Recommendations - Newser
Analyzing drawdowns of Atossa Therapeutics Inc. with statistical toolsMarket Volume Summary & Real-Time Volume Triggers - Newser
How to track smart money flows in Atossa Therapeutics Inc.Earnings Growth Report & Risk Controlled Daily Plans - Newser
Measuring Atossa Therapeutics Inc.’s beta against major indicesEarnings Beat & Technical Buy Zone Confirmation - Newser
Is Atossa Therapeutics Inc. stock showing strong momentum2025 Historical Comparison & Expert Curated Trade Setups - khodrobank.com
Detecting support and resistance levels for Atossa Therapeutics Inc.Jobs Report & Growth Oriented Trading Recommendations - Newser
Market reaction to Atossa Therapeutics Inc.’s recent newsMarket Performance Recap & Fast Exit and Entry Strategy Plans - Newser
Will Atossa Therapeutics Inc. stock go up soonQuarterly Risk Review & Daily Chart Pattern Signal Reports - Newser
Leading vs lagging indicators on Atossa Therapeutics Inc. performanceJuly 2025 Action & Daily Growth Stock Investment Tips - Newser
We're Hopeful That Atossa Therapeutics (NASDAQ:ATOS) Will Use Its Cash Wisely - Yahoo Finance
Does Atossa Therapeutics Inc. have a competitive edgeJuly 2025 Final Week & Fast Entry Momentum Trade Alerts - khodrobank.com
Atossa Therapeutics and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Florida Times-Union
Statistical indicators supporting Atossa Therapeutics Inc.’s strength2025 Market Trends & Scalable Portfolio Growth Methods - Newser
Using data models to predict Atossa Therapeutics Inc. stock movement2025 Top Gainers & Technical Pattern Alert System - Newser
Top chart patterns to watch in Atossa Therapeutics Inc.July 2025 Price Swings & Weekly Breakout Stock Alerts - Newser
Is Atossa Therapeutics Inc. undervalued by DCF analysisJuly 2025 Update & Risk Controlled Swing Trade Alerts - khodrobank.com
Does Atossa Therapeutics Inc. have strong EBITDA marginsWeekly Stock Analysis & Risk Controlled Stock Alerts - khodrobank.com
Is Atossa Therapeutics Inc. likely to announce a buyback2025 Breakouts & Breakdowns & Weekly Return Optimization Alerts - khodrobank.com
Institutional scanner results for Atossa Therapeutics Inc.Quarterly Market Summary & Low Risk High Reward Trade Ideas - Newser
Multi factor analysis applied to Atossa Therapeutics Inc.Short Setup & Fast Gain Stock Trading Tips - Newser
Visualizing Atossa Therapeutics Inc. stock with heatmapsProduct Launch & Fast Momentum Entry Tips - Newser
Evaluating Atossa Therapeutics Inc. with trendline analysisAnalyst Upgrade & Verified Entry Point Signals - Newser
Atossa Therapeutics Inc Azioni (ATOS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Atossa Therapeutics Inc Azioni (ATOS) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Remmel H. Lawrence | Director |
Mar 26 '25 |
Buy |
0.70 |
10,000 |
7,000 |
10,257 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):